---
figid: PMC5769535__13046_2018_674_Fig1_HTML
figtitle: Neurotransmitters signalling pathways in cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC5769535
filename: 13046_2018_674_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5769535/figure/Fig1/
number: F1
caption: Neurotransmitters signalling pathways in cancer. Cancer neuro-immune communication
  is through the release of neurotransmitters using different signalling kinases which
  promote cancer progression via metastasis. Perineural invasion mediate cancer metastasis
  through the release of the NGF and GDNF via the activation of different signaling
  pathway. Ach, acetylcholine; β2-AR, β2-adrenergic receptor;cAMP, cyclic adenosine
  monophosphate; DA, dopamine; DR, dopamine receptor; EGFR, epidermal growth factor
  receptor;EMT,epithelial–mesenchymal transition; ERK1/2, extracellular signal-regulated
  kinase;FAK, focal adhesion kinase; GABA, gamma-aminobutyric acid; GABAB,gamma-aminobutyric
  acid receptorB;GDNF, glial cell line-derived neurotrophic factor; GFRα, glial cell
  line-derived neurotrophic factor receptor 1;ICAM-1, intercellular adhesion molecule-1;
  JAK2,janus kinase 2;MEK, MAPK/ERK kinase;mTOR, mammalian/mechanistic target of rapamycin;MMP,
  matrix metallopeptidase;MAPK,mitogen-activated protein kinases;RAF, mitogen activated
  protein kinase;RAS, mitogen activated protein kinase;mAChRs, muscarinic acetylcholine
  receptors;NK-1R, neurokinin-1 receptor; NGF, nerve growth factor;nAChR, nicotinic
  acetylcholine receptor;NE, norepinephrine;NF-kB, nuclear factor-kappa B;PLC, phospholipase
  C; PI3K, phosphoinositide 3-kinase;PKA, protein kinase A;PKC, protein kinase C;RET,
  proto-oncogene;AKT, serine/threonine kinase or protein kinase B;STAT3,signal transducer
  and activator of transcription 3; SP,substance P;TrkA,tropomyosin related kinase
  A
papertitle: Role of the nervous system in cancer metastasis.
reftext: Nyanbol Kuol, et al. J Exp Clin Cancer Res. 2018;37:5.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9429954
figid_alias: PMC5769535__F1
figtype: Figure
redirect_from: /figures/PMC5769535__F1
ndex: f941a9a7-df02-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5769535__13046_2018_674_Fig1_HTML.html
  '@type': Dataset
  description: Neurotransmitters signalling pathways in cancer. Cancer neuro-immune
    communication is through the release of neurotransmitters using different signalling
    kinases which promote cancer progression via metastasis. Perineural invasion mediate
    cancer metastasis through the release of the NGF and GDNF via the activation of
    different signaling pathway. Ach, acetylcholine; β2-AR, β2-adrenergic receptor;cAMP,
    cyclic adenosine monophosphate; DA, dopamine; DR, dopamine receptor; EGFR, epidermal
    growth factor receptor;EMT,epithelial–mesenchymal transition; ERK1/2, extracellular
    signal-regulated kinase;FAK, focal adhesion kinase; GABA, gamma-aminobutyric acid;
    GABAB,gamma-aminobutyric acid receptorB;GDNF, glial cell line-derived neurotrophic
    factor; GFRα, glial cell line-derived neurotrophic factor receptor 1;ICAM-1, intercellular
    adhesion molecule-1; JAK2,janus kinase 2;MEK, MAPK/ERK kinase;mTOR, mammalian/mechanistic
    target of rapamycin;MMP, matrix metallopeptidase;MAPK,mitogen-activated protein
    kinases;RAF, mitogen activated protein kinase;RAS, mitogen activated protein kinase;mAChRs,
    muscarinic acetylcholine receptors;NK-1R, neurokinin-1 receptor; NGF, nerve growth
    factor;nAChR, nicotinic acetylcholine receptor;NE, norepinephrine;NF-kB, nuclear
    factor-kappa B;PLC, phospholipase C; PI3K, phosphoinositide 3-kinase;PKA, protein
    kinase A;PKC, protein kinase C;RET, proto-oncogene;AKT, serine/threonine kinase
    or protein kinase B;STAT3,signal transducer and activator of transcription 3;
    SP,substance P;TrkA,tropomyosin related kinase A
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - da
  - Gdnf
  - Ngf
  - Chrna7
  - Tacr1
  - pc
  - pk
  - Pik3r1
  - Mmp2
  - Itk
  - Slc22a3
  - Ephb2
  - Mapk1
  - ras
  - Hras
  - Kras
  - Rem1
  - Jak2
  - Egfr
  - Ret
  - Hspg2
  - Akt1
  - Ptk2
  - Mtor
  - Nfkb1
  - Stat3
  - Icam1
  - Mdk
  - FGFR3
  - GDNF
  - NGF
  - CHRNA4
  - TACR1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MMP2
  - ITK
  - SLC22A3
  - EPHB2
  - MAPK1
  - MAPK3
  - KRAS
  - HRAS
  - NRAS
  - JAK2
  - EGFR
  - RET
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - AKT1
  - AKT2
  - AKT3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PTK2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MTOR
  - NFKB1
  - STAT3
  - ICAM1
  - GER
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - Chrnb1
  - Chrne
  - Prkcg
  - Pik3cg
  - Ephb1
  - Ne
  - nAChRalpha2
  - GABA-B-R1
  - Rdl
  - Gabat
  - achi
  - emc
  - Dr
  - nAChRalpha3
  - nAChRalpha7
  - nAChRbeta3
  - nAChRalpha6
  - nAChRalpha5
  - nAChRbeta1
  - nAChRalpha4
  - nAChRalpha1
  - nAChRbeta2
  - mAChR-A
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Erk7
  - rl
  - Ras64B
  - Ras85D
  - reticulated
  - reti
  - rets
  - norpA
  - sl
  - Plc21C
  - Akt
  - Rst(2)At
  - MKP-4
  - p38b
  - Fak
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Tor
  - Dif
  - dl
  - Rel
  - Gmer
  - Fs(3)Ger
  - Dsor1
  - Mtk
  - GABA
  - Cancer
  - Lung cancer
---
